Analyst
UBS
Equibles does not estimate personal net worth.
Selena is recorded as Analyst at UBS. Selena has spoken on 1 earnings call across 1 company, most recently for Crinetics Pharmaceuticals, Inc. on August 7, 2025. The companies whose calls Selena spoke on are classified in the Healthcare sector.
“For the Global CAH Phase III study, what are your expectations around placebo response and any potential impact from different geographies?”
UBS
Analyst
Transcript header (unverified)
Crinetics Pharmaceuticals, Inc.
Biotechnology · Healthcare
Crinetics Pharmaceuticals, Inc. Q2 FY2025 Earnings Call
Crinetics Pharmaceuticals, Inc.
